
Precise Bio's 3D-Printed Corneal Endothelium Enters 15-Patient Phase 1 Trial
Precise Bio's 3D-bioprinted corneal endothelium implant, PB-001, has entered a Phase 1 trial with a planned enrollment of 15 people. Human results remain unpublished, leaving safety and 12-month vision, corneal thickness, and cell density outcomes still to be confirmed.








